Plain-English translation of NCT06814314 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Researchers know that antipsychotic medications can sometimes cause metabolic problems (like weight gain, high blood pressure, or high blood sugar) in children and teens. This study collects blood samples to look for early genetic warning signs in the blood that might predict who will develop these problems when taking antipsychotics. By understanding these warning signs, doctors could eventually personalize treatment to reduce metabolic risks.
Antipsychotic medications help manage serious behavioral and emotional conditions in young people, but they can have side effects related to metabolism and weight. Right now, doctors have no way to predict ahead of time which young patients will experience these metabolic problems. This study aims to find genetic markers that could help doctors identify at-risk patients early and adjust treatment plans accordingly.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the research clinic where researchers will take a small blood sample from your arm โ similar to a routine blood test at a doctor's office. The blood sample will be analyzed to look at gene activity related to metabolism. Depending on which group you're in, you may be asked about your current medications, weight, and health history. The study is not testing a new drug โ it's purely observational research to understand how the body responds to existing antipsychotic treatments.
AI-generated summary from trial data ยท Jun 22, 2026 ยท Not medical advice
Italy